Novel Insights in TKI Resistance in BCR:: ABL1-Positive B-Cell Acute Lymphoblastic Leukemia Beyond Kinase Domain Mutations

被引：1
|
作者：
Van Outersterp, Inge [1 ]
Reichert, Caitlin E. J. [1 ]
Boeree, Aurelie [1 ]
Van de Ven, Cesca [1 ]
Kruisinga, Brian [1 ]
de Groot-Kruseman, Hester A. [1 ]
Escherich, Gabriele [2 ]
Rijneveld, Anita W. [3 ]
Boer, Judith M. [1 ]
den Boer, Monique L. [1 ,4 ]
机构：
[1] Princess Maxima Ctr Pediat Oncol, Utrectht, Netherlands
[2] Univ Med Ctr Hamburg Eppendorf, Clin Pediat Hematol & Oncol, Hamburg, Germany
[3] Erasmus MC, Dept Hematol, Rotterdam, Netherlands
[4] Erasmus MC, Dept Pediat Oncol Hematol, Sophia Childrens Hosp, Rotterdam, Netherlands
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-179704
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] BCR::ABL1-Like B-Cell Acute Lymphoblastic Leukemia with BCR::PDGFRA Fusion: A Case Report and Literature Review
    Hua, Jiamin
    Yan, Han
    Qian, Xiangyu
    Gao, Dongyan
    Yang, Bo
    Xu, Yubing
    Li, Jianfeng
    Weng, Xiangqin
    Zhu, Yongmei
    Wang, Jin
    ACTA HAEMATOLOGICA, 2024, 147 (04) : 467 - 474
  • [32] The Promising Third-Generation TKI Olverembatinib in Adult BCR::ABL1-Positive Acute Lymphoblastic Leukemia with T315I Mutation and Relapsed/Refractory Disease
    Liu, Weiyang
    Wang, Cheng
    Tang, Sijie
    Ren, Jiayi
    Peng, Lijun
    Zhu, Yongmei
    Weng, Xiangqin
    Ouyang, Wanyan
    Xu, Jie
    Liu, Yuanfang
    Zhang, Weiping
    Wang, Jin
    Mi, Jian-Qing
    BLOOD, 2023, 142
  • [33] SFPQ-ABL1 and BCR-ABL1 use different signaling networks to drive B-cell acute lymphoblastic leukemia
    Brown, Lauren M.
    Hediyeh-Zadeh, Soroor
    Sadras, Teresa
    Huckstep, Hannah
    Sandow, Jarrod J.
    Bartolo, Ray C.
    Kosasih, Hansen J.
    Davidson, Nadia M.
    Schmidt, Breon
    Bjelosevic, Stefan
    Johnstone, Ricky
    Webb, Andrew, I
    Khaw, Seong L.
    Oshlack, Alicia
    Davis, Melissa J.
    Ekert, Paul G.
    BLOOD ADVANCES, 2022, 6 (07) : 2373 - 2387
  • [34] BCR-ABL1 gene rearrangement as a subclonal change in ETV6-RUNX1-positive B-cell acute lymphoblastic leukemia
    Dun, Karen A.
    Vanhaeften, Rob
    Batt, Tracey J.
    Riley, Louise A.
    Diano, Giuseppe
    Williamson, Jan
    BLOOD ADVANCES, 2016, 1 (02) : 132 - 138
  • [35] Rac GTPase activation mediates BCR-ABL-induced B-cell acute lymphoblastic leukemia
    Sanchez-Aguilera, Abel
    Sengupta, Amitava
    Williams, David A.
    Cancelas, Jose A.
    EXPERIMENTAL HEMATOLOGY, 2008, 36 (07) : S3 - S3
  • [36] A Novel BCR-ABL1 Degrader, Ubx-362, Can Overcome Resistance By BCR-ABL1 Kinase Domain Mutations in Chronic Myeloid Leukemia
    Lim, Ye Seul
    Jeong, Na-Rae
    Yoo, Sun-Mi
    Kim, Han Wool
    Lee, Song Hee
    Kim, Dong-Wook
    BLOOD, 2023, 142
  • [37] The ABL and JAK Tyrosine Kinase Pathways Are Co-Activated in BCR/ABL1 Positive Acute Lymphoblastic Leukemia
    Bhagavathi, S.
    Aviv, H.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 958 - 958
  • [38] Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis
    Soverini, Simona
    Vitale, Antonella
    Poerio, Angela
    Gnani, Alessandra
    Colarossi, Sabrina
    Iacobucci, Ilaria
    Cimino, Giuseppe
    Elia, Loredana
    Lonetti, Annalisa
    Vignetti, Marco
    Paolini, Stefania
    Meloni, Giovanna
    di Maio, Valeria
    Papayannidis, Cristina
    Amabile, Marilina
    Guarini, Anna
    Baccarani, Michele
    Martinelli, Giovanni
    Foa, Robin
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (04): : 552 - 557
  • [39] Pattern and evolution of BCR-ABL kinase domain mutations in patients with Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL) developing resistance to imatinib.
    Pfeifer, H
    Wassmann, B
    Pavlova, A
    Mueller, M
    Wunderle, L
    Brueck, P
    Oldenburg, J
    Hochhaus, A
    Gschaidmeier, H
    Hoelzer, D
    Ottmann, OG
    BLOOD, 2005, 106 (11) : 46A - 47A
  • [40] Drug Resistance and BCR-ABL Kinase Domain Mutations in Philadelphia Chromosome- Positive Acute Lymphoblastic Leukemia From the Imatinib to the Second- Generation Tyrosine Kinase Inhibitor Era
    Soverini, Simona
    De Benedittis, Caterina
    Papayannidis, Cristina
    Paolini, Stefania
    Venturi, Claudia
    Iacobucci, Ilaria
    Luppi, Mario
    Bresciani, Paola
    Salvucci, Marzia
    Russo, Domenico
    Sica, Simona
    Orlandi, Ester
    Intermesoli, Tamara
    Gozzini, Antonella
    Bonifacio, Massimiliano
    Rigolin, Gian Matteo
    Pane, Fabrizio
    Baccarani, Michele
    Cavo, Michele
    Martinelli, Giovanni
    CANCER, 2014, 120 (07) : 1002 - 1009
12345